mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.54 |
0.07 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.07 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.07 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |